您当前的位置:国际号刊-季刊 > 基础医学 >
交叉学科医学(英文)(Interdisciplinary Medicine)(国际刊号)

交叉学科医学(英文)(Interdisciplinary Medicine)(国际刊号)

基本信息
  • 主管单位:

  • 主办单位:

    南方医科大学南方医院与Wiley出版集团

  • 国际刊号:

    2832-6237;EISSN 2832-6245

  • 国内刊号:

  • 学科分类:

    基础医学

  • 字数:

    -

  • 有无基金:

     

  • 周期:

    国际号刊-季刊

  • 特殊属性:

    外文期刊

联系信息
  • 电话:

  • 邮箱:

    intmed@smu.edu.cnimedicine@wiley.com(官网邮箱)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

  • 级别:

期刊简介

《交叉学科医学(英文)(Interdisciplinary Medicine)(国际刊号)》期刊已被查看:

更新频次

单位占比

一作占比

投稿指南

1、该刊只有国际刊号!

2、投稿方式:在线投稿。

3、官网网址:

https://onlinelibrary.wiley.com/journal/28326245

4、投稿系统:

https://mc.manuscriptcentral.com/imedicine

5、主办单位相关网址:

https://www.nflab.net/news/2800.cshtml

6、出刊日期:季刊,一年出版4期。

2022年8月31日星期三

Interdisciplinary Medicine简介

【微信公众号“南方检验医学(NFLAB-NET)”信息】

Interdisciplinary MEDICINE(以下简称IMed)是由南方医科大学南方医院与Wiley出版集团联合新创办的开放获取国际学术期刊。期刊致力于报道以多学科交叉为研究手段的医学创新科技成果,旨在为医学与生命科学、化学、物理学、信息科学、工程与材料科学等不同学科的交叉融合研究搭建高水平的学术交流平台。IMed主编由南方医科大学南方医院郑磊教授担任,编委团队由来自世界各地不同学科背景的杰出专家学者组成。

Interdisciplinary Medicine(IMed)期刊致力于报道以多学科交叉为研究手段的医学创新科技成果。本刊接受的投稿类型多种多样,包括:研究性文章(Research Article)、综述性文章(Review)、通讯性文章(Short Communication)及观点性文章(Perspective)等。期刊编委成员由知名研究机构的顶尖科学家组成,读者群体包括全球学术界和医学界的科研人员、临床医生等。

IMed期刊欢迎的稿件领域包括但不限于:

• Advances in laboratory medicine

• Biomaterials

• Artificial intelligence-driven health science

• Precision and personalized medicine

• Computational biology

• Molecular therapy

• Drug delivery

• Tissue engineering

• Biosensors

• Nanobiotechnology

• Imaging and nuclear medicine

• Photo-, electro-, magnetic, acoustic, and mechanical medicine

所有投稿将经过标准且严格的同行评审。如果有任何疑问,请发送电子邮件至intmed@smu.edu.cn咨询。

文章应通过ScholarOne在线提交:https://mc.manuscriptcentral.com/imedicine

期刊主页:https://onlinelibrary.wiley.com/journal/28326245

作者指南Author Guidelines

【官网信息】

1. SUBMISSION

Thank you for your kind interest in Interdisciplinary Medicine. Submissions have to consist of content that has not been published or submitted for publication elsewhere except those as the brief abstracts in the proceedings of conferences or symposiums.

All submissions will be handled and processed using the ScholarOne online submission system. Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/imedicine.

A cover letter should be uploaded in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file.

The cover letter must contain:

A statement confirming the paper has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

An acknowledgment that all authors have contributed significantly; and in keeping with the latest guidelines of the International Committee of the Journal Editors, each author’s contribution to the paper is to be described, i.e., what role each author participated in.

A statement confirming that all authors are in agreement with the content of the manuscript.

In addition, authors should clearly state the motivation behind and the novelty of their research in the cover letter. Authors should also clarify key results and the advances made compared with their previous work.

Interdisciplinary Medicine now offers Free Format submission for a simplified and streamlined submission process for New Submissions.

Before you submit, you will need:

Your manuscript: this should be an editable file including text, figures, and tables, or separate files—whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. Figures should be uploaded in the highest resolution possible. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.

An ORCID ID, freely available at https://orcid.org.

The title page of the manuscript, including:

Your co-author details, including affiliation and email address.

Statements relating to our ethics and integrity policies, which may include any of the following

data availability statement

funding statement

conflict of interest disclosure

ethics approval statement

patient consent statement

permission to reproduce material from other sources

clinical trial registration

2. AIMS AND SCOPE

Interdisciplinary Medicine is a new open-access, peer-reviewed, and rapid-publication journal aims to publish cutting-edge significant works related to any fields of biomedicine that present an interdisciplinary dimension. The journal will publish a broad spectrum of research on increasingly multi- and interdisciplinary studies between medicine and other disciplines, such as biology, chemistry, materials, physics, and information science, etc.

Topics of particular interests include, but are not limited to the following:

Advances in laboratory medicine

Artificial intelligence-driven health science

Biomaterials

Biosensors

Computational biology

Drug delivery

Imaging and nuclear medicine

Molecular therapy

Nanobiotechnology

Precision and personalized medicine

Photo-, electro-, magnetic, acoustic, and mechanical medicine

……

更多详情:

https://onlinelibrary.wiley.com/page/journal/28326245/homepage/author-guidelines

中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。